SNY (Sanofi) שווי פירמה כולל

The French behemoth Sanofi (SNY) is modernizing its plants to reduce its carbon footprint and is implementing eco-friendly packaging. The asset's price trajectory on GURU.Markets shows that the Enterprise Value is 119950.06. Sanofi leverages its colossal scientific potential in developing antibodies and vaccines, while surging demand for Dupixent fuels current growth, offsetting the aging of its legacy drug portfolio.

Sanofi (SNY) rebalancing toward immunology and vaccines while scaling back its consumer segment directly impacts the market valuation of its assets. Summing market capitalization and net debt determines the actual business buyout cost, allowing investors to assess the company's real price adjusted for liquidity by analyzing enterprise value trends to avoid entering the asset at local peaks.